Immunity, Hypoxia, and Metabolism–the Ménage à Trois of Cancer: Implications for Immunotherapy

Cites (808)

Items 401–600 of 808

1. Monocarboxylic Acid Transport
   Andrew P. Halestrap · 2013 · Comprehensive physiology
2. Fatty acid oxidation in macrophage polarization
   Mitsunori Nomura, Jie Liu, Ilsa I. Rovira, Elsie Gonzalez-Hurtado, Jieun Lee, Michael J. Wolfgang, Toren Finkel · 2016 · Nature Immunology
3. Etomoxir Actions on Regulatory and Memory T Cells Are Independent of Cpt1a-Mediated Fatty Acid Oxidation
   Brenda Raud, Dominic Guy Roy, Ajit S. Divakaruni, Tatyana N. Tarasenko, Raimo Franke, Eric H. Ma, Bożena Samborska, Wei Yuan Hsieh, Alison Wong, Philipp Stüve et al. · 2018 · Cell Metabolism
4. Improving the metabolic fidelity of cancer models with a physiological cell culture medium
   Johan Vande Voorde, Tobias Ackermann, Nadja Pfetzer, David P. Sumpton, Gillian Mackay, Gabriela Kalna, Colin Nixon, Karen Blyth, Eyal Gottlieb, Saverio Tardito · 2019 · Science Advances
5. Diverse Functions of Macrophages in Different Tumor Microenvironments
   Ming Yang, Daniel McKay, Jeffrey W. Pollard, Claire E. Lewis · 2018 · Cancer Research
6. The mitochondrial citrate carrier: a new player in inflammation
   Vittoria Infantino, Paolo Convertini, Liana Cucci, Maria Antonietta Panaro, Maria Antonietta Di Noia, Rosa Calvello, Ferdinando Palmieri, Vito Iacobazzi · 2011 · Biochemical Journal
7. CD4 + T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
   Dominik Mumberg, Paul A. Monach, Sherry S. Wanderling, Mary Philip, Alicia Y. Toledano, Robert D. Schreiber, Hans Wilhelm Schreiber · 1999 · Proceedings of the National Academy of Sciences
8. Predominant infiltration of macrophages and CD8 + T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
   Osamu Kawai, Genichiro Ishii, Kaoru Kubota, Yukinori Murata, Yoichi Naito, Tetsuya Mizuno, Keiju Aokage, Nagahiro Saijo, Yutaka Nishiwaki, Akihiko Gemma et al. · 2008 · Cancer
9. Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
   Róisín M. Loftus, Nadine Aßmann, Nidhi Kedia-Mehta, Katie O’Brien, Arianne Garcia, Conor Scott Gillespie, Jens L. Hukelmann, Peter Josef Oefner, Angus I. Lamond, Clair M. Gardiner et al. · 2018 · Nature Communications
10. Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
    Laetitia Aymeric, Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Isabelle Martins, Guido Kroemer, Mark John Smyth, Laurence Zitvogel · 2010 · Cancer Research
11. 18 F-FDG PET/CT Imaging In Oncology
    Ahmad Almuhaideb, Nikolaos D. Papathanasiou, Jamshed B Bomanji · 2011 · Annals of Saudi Medicine
12. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences
    Janesh Pillay, Tamar Tak, Vera M. Kamp, Leo Koenderman · 2013 · Cellular and Molecular Life Sciences
13. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
    Hams, Emily, Armstrong, Michelle E., Barlow, Jillian L., Saunders, Sean P., Schwartz, Christian, Cooke, Gordon, Fahy, Ruairi J., Crotty, Thomas B., Hirani, Nikhil, Flynn, Robin J. et al. · 2014 · Proceedings of the National Academy of Sciences
14. Srebp-controlled glucose metabolism is essential for NK cell functional responses
    Assmann, Nadine, O'Brien, Katie L, Donnelly, Raymond P, Dyck, Lydia, Zaiatz-Bittencourt, Vanessa, Loftus, Róisín M, Heinrich, Paul, Oefner, Peter J, Lynch, Lydia, Gardiner, Clair M et al. · 2017 · Nature Immunology
15. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells.
    Jurij Rozhin, Mansoureh Sameni, Grace Ziegler, Bonnie F. Sloane · 1994 · PubMed
16. HLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
    Edgardo Delfino Carosella, Philippe Moreau, Joël LeMaoult, Magali Le Discorde, Jean B. Dausset, Nathalie Rouas‐Freiss · 2003 · Advances in immunology
17. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice
    Hanh K. Le, Laura Graham, Esther Cha, Johanna K. Morales, Masoud H. Manjili, Harry D. Bear · 2009 · International Immunopharmacology
18. Cancer regression in patients with metastatic melanoma after the transfer of autologous antitumor lymphocytes
    Steven A. Rosenberg, Mark E. Dudley · 2004 · Proceedings of the National Academy of Sciences
19. Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
    Jaclyn Sceneay, Melvyn T. Chow, Anna Chen, Heloise M. Halse, Christina S.F. Wong, Daniel Mark Andrews, Erica K. Sloan, Belinda S. Parker, David D.L. Bowtell, Mark John Smyth et al. · 2012 · Cancer Research
20. The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells
    Eric A. Newsholme, B. Crabtree, Mohammed S. Ardawi · 1985 · Bioscience Reports
21. Multicenter Phase II Study of Mogamulizumab (KW-0761), a Defucosylated Anti-CC Chemokine Receptor 4 Antibody, in Patients With Relapsed Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma
    Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, Masafumi Taniwaki, Kiyoshi Ando, Kensei Tobinai, Katsuya Fujimoto, Kazuhito Yamamoto, Toshihiro Miyamoto, Naokuni Uike et al. · 2014 · Journal of Clinical Oncology
22. Etomoxir Inhibits Macrophage Polarization by Disrupting CoA Homeostasis
    Ajit S. Divakaruni, Wei Yuan Hsieh, Lucía Minarrieta, Tin Duong, Kristen K.O. Kim, Brandon R. Desousa, Alexander Y. Andreyev, Caitlyn E. Bowman, Kacey L. Caradonna, Brian P. Dranka et al. · 2018 · Cell Metabolism
23. Memory CD8 + T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal Function
    Balmer, Maria L., Ma, Eric H., Bantug, Glenn R., Grählert, Jasmin, Pfister, Simona, Glatter, Timo, Jauch, Annaïse, Dimeloe, Sarah, Slack, Emma, Dehio, Philippe et al. · 2016 · Immunity
24. Metabolic requirements for neutrophil extracellular traps formation
    Oscar Rodríguez‐Espinosa, Oscar Rojas-Espinosa, María Maximina Bertha Moreno‐Altamirano, Edgar Oliver López‐Villegas, Francisco Javier Sánchez‐García · 2014 · Immunology
25. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
    Inbal Mishalian, Rachel Bayuh, Liran Levy, Lida Zolotarov, Janna Michaeli, Zvi Gregorio Fridlender · 2013 · Cancer Immunology Immunotherapy
26. PPAR-Induced Fatty Acid Oxidation in T Cells Increases the Number of Tumor-Reactive CD8+ T Cells and Facilitates Anti–PD-1 Therapy
    Partha Sarathi Chowdhury, Kenji Chamoto, Alok Kumar, Tasuku Honjo · 2018 · Cancer Immunology Research
27. Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression
    Christopher M. Rice, Luke C. Davies, Jeffrey J. Subleski, Nunziata Maio, Marieli Gonzalez-Cotto, Caroline Andrews, Nimit L. Patel, Erika Mariana Palmieri, Jonathan M. Weiss, Jungmin Lee et al. · 2018 · Nature Communications
28. Beyond the increasing complexity of the immunomodulatory HLA-G molecule
    Carosella, Edgardo D., Favier, Benoit, Rouas-Freiss, Nathalie, Moreau, Philippe, LeMaoult, Joel · 2008 · Blood
29. Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
    Meixiao Shen, Pingping Hu, Frede N. Donskov, Guanghui Wang, Qi Liu, Jiajun Du · 2014 · PLoS ONE
30. Selective Inhibition of Tumor Growth by Clonal NK Cells Expressing an ErbB2/HER2-Specific Chimeric Antigen Receptor
    Kurt Schönfeld, Christiane Sahm, Congcong Zhang, Sonja Naundorf, Christian Brendel, Marcus Odendahl, Paulina Nowakowska, Halvard B. Bonig, Ulrike Koehl, Stephan Kloeß et al. · 2014 · Molecular Therapy
31. Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
    Xixi Zhao, Jingkun Qu, Yuchen Sun, Jizhao Wang, Xu Liu, Feidi Wang, Hong Zhang, Wen Wang, Xingcong Ma, Xiaoyan Gao et al. · 2017 · Oncotarget
32. The Emerging Role of B Cells in Tumor Immunity
    Peiling Tsou, Hiroyuki Katayama, Edwin Justin Ostrin, Samir Hanash · 2016 · Cancer Research
33. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
    Baginska, Joanna, Viry, Elodie, Berchem, Guy, Poli, Aurélie, Noman, Muhammad Zaeem, van Moer, Kris, Medves, Sandrine, Zimmer, Jacques, Oudin, Anaïs, Niclou, Simone P. et al. · 2013 · Proceedings of the National Academy of Sciences
34. Akt Inhibition Enhances Expansion of Potent Tumor-Specific Lymphocytes with Memory Cell Characteristics
    Joseph Garfield Crompton, Madhusudhanan Sukumar, Rahul Roychoudhuri, David C. Clever, Alena Gros, Robert L Eil, Eric Tran, Ken‐ichi Hanada, Zhiya Yu, Douglas C. Palmer et al. · 2014 · Cancer Research
35. Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions
    Seth B. Coffelt, Andrea Oliver Tal, Alexander Scholz, Michele De Palma, Sunil S. Patel, Carmen Urbich, Subhra Kumar Biswas, Craig Murdoch, Karl Heinz Plate, Yvonne Reiss et al. · 2010 · Cancer Research
36. Fatty acid metabolism complements glycolysis in the selective regulatory T cell expansion during tumor growth
    Ilenia Pacella, Claudio Procaccini, Chiara Focaccetti, Stefano Miacci, Eleonora Timperi, Deriggio Faicchia, Martina Severa, Fabiana Rizzo, Eliana Marina Coccia, Fabrizia Bonacina et al. · 2018 · Proceedings of the National Academy of Sciences
37. The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
    Charles, Kellie A., Kulbe, Hagen, Soper, Robin, Escorcio-Correia, Monica, Lawrence, Toby, Schultheis, Anne, Chakravarty, Probir, Thompson, Richard G., Kollias, George, Smyth, John F. et al. · 2009 · Journal of Clinical Investigation
38. CD25 Blockade Depletes and Selectively Reprograms Regulatory T Cells in Concert with Immunotherapy in Cancer Patients
    Andrew J. Rech, Rosemarie Mick, Sunil Martin, Adri Recio, Nicole A. Aqui, Daniel J. Powell, Theresa A. Colligon, Jennifer A. Trosko, Leah I. Leinbach, Charles H. Pletcher et al. · 2012 · Science Translational Medicine
39. CTLA-4 blockade in tumor models: an overview of preclinical and translational research.
    Joseph F. Grosso, Maria Jure‐Kunkel · 2013 · Europe PMC (PubMed Central)
40. SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling
    Victor S. Cortez, Tyler Kent Ulland, Luisa Cervantes‐Barragán, Jennifer K. Bando, Michelle L. Robinette, Qianli Wang, Andrew J. White, Susan Gilfillan, Marina Cella, Marco Colonna · 2017 · Nature Immunology
41. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression
    Farbod Shojaei, Mallika Singh, Jennifer D. Thompson, Napoleone Ferrara · 2008 · Proceedings of the National Academy of Sciences
42. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: From biology to clinical use
    Jaromı́r Pastorek, Silvia Pastoreková · 2014 · Seminars in Cancer Biology
43. Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function
    Duojiao Wu, David E. Sanin, Bart Everts, Qiongyu Chen, Jing Qiu, Michael D. Buck, Annette E. Patterson, Amber M. Smith, Chih‐Hao Chang, Zhi‐Ping Liu et al. · 2016 · Immunity
44. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model
    H Schmidt, Lars Bastholt, Poul Flemming Geertsen, Ib Jarle Christensen, S. Larsen, Julie Gehl, Hans von der Maase · 2005 · British Journal of Cancer
45. IL-7-Induced Glycerol Transport and TAG Synthesis Promotes Memory CD8+ T Cell Longevity
    Guoliang Cui, Matthew M. Staron, Simon M. Gray, Ping‐Chih Ho, Robert A. Amezquita, Jingxia Wu, Susan M. Kaech · 2015 · Cell
46. Trial watch: IDO inhibitors in cancer therapy
    Erika Vacchelli, Fernando Aranda, Alexander M.M. Eggermont, Catherine Sautès‐Fridman, Éric Tartour, Eugene Paul Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2014 · OncoImmunology
47. Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells
    Sinéad E. Keating, Vanessa Zaiatz-Bittencourt, Róisín M. Loftus, Ciara Keane, Kiva Brennan, David K. Finlay, Clair M. Gardiner · 2016 · The Journal of Immunology
48. Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
    Paul A. Beavis, Melissa A. Henderson, Lauren Giuffrida, Jane K. Mills, Kevin Sek, Ryan Stanley Cross, Alexander J. Davenport, Liza B. John, Sherly Mardiana, Clare Y. Slaney et al. · 2017 · Journal of Clinical Investigation
49. Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations
    Kerry S. Campbell, Amanda K. Purdy · 2011 · Immunology
50. CTLA-4 is constitutively expressed on tumor cells and can trigger apoptosis upon ligand interaction
    Elisabetta Contardi, Giulio Lelio Palmisano, Pier Luigi Tazzari, Alberto Maria Martelli, Federica Falà, Marina Fabbi, Tomohiro Kato, Enrico Lucarelli, Davide María Donati, Letizia Polito et al. · 2005 · International Journal of Cancer
51. PI3K-Akt-mTORC1-S6K1/2 Axis Controls Th17 Differentiation by Regulating Gfi1 Expression and Nuclear Translocation of RORγ
    Yutaka Kurebayashi, Shigenori Nagai, Ai Ikejiri, Masashi Ohtani, Kenji Ichiyama, Yukiko Baba, Taketo Yamada, Shohei Egami, Takayuki Hoshii, Atsushi Hirao et al. · 2012 · Cell Reports
52. Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia
    Fang, Hsin-Yu, Hughes, Russell, Murdoch, Craig, Coffelt, Seth B., Biswas, Subhra K., Harris, Adrian L., Johnson, Randall S., Imityaz, Hongxia Z., Simon, M. Celeste, Fredlund, Erik et al. · 2009 · Blood
53. Pannexin-1 hemichannel–mediated ATP release together with P2X1 and P2X4 receptors regulate T-cell activation at the immune synapse
    Tobias Woehrle, Linda Yip, Abdallah Elkhal, Yuka Sumi, Yu Chen, Yongli Yao, Paul A. Insel, Wolfgang Georg JUNGER · 2010 · Blood
54. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer
    Ole Audun Werner Haabeth, Kristina Berg Lorvik, Clara Louise Hammarström, Ian M. Donaldson, Guttorm Haraldsen, Bjarne Bogen, Alexandre Corthay · 2011 · Nature Communications
55. Identification of Innate IL-5–Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity
    Masashi Ikutani, Tsutomu Yanagibashi, Masaru Ogasawara, Koichi Tsuneyama, Seiji Yamamoto, Yuichi Hattori, Taku Kouro, Atsuko Itakura, Yoshinori Nagai, Satoshi Τακακι et al. · 2011 · The Journal of Immunology
56. Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
    Garaude, Johan, Acín-Pérez, Rebeca, Martínez-Cano, Sarai, Enamorado, Michel, Ugolini, Matteo, Nistal-Villán, Estanislao, Hervás-Stubbs, Sandra, Pelegrín, Pablo, Sander, Leif E, Enríquez, José A et al. · 2016 · Nature Immunology
57. 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses
    Ashley V. Menk, Nicole E. Scharping, Dayana B. Rivadeneira, Michael Joseph Calderon, McLane J. Watson, Deanna Dunstane, Simon C. Watkins, Greg M. Delgoffe · 2018 · The Journal of Experimental Medicine
58. Activation-Specific Metabolic Requirements for NK Cell IFN-γ Production
    Molly P. Keppel, Nermina Saucier, Annelise Yoo Mah-Som, Tiphanie P. Vogel, Megan A. Cooper · 2015 · The Journal of Immunology
59. Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
    Görgün, Güllü, Samur, Mehmet K., Cowens, Kristen B., Paula, Steven, Bianchi, Giada, Anderson, Julie E., White, Randie E., Singh, Ahaana, Ohguchi, Hiroto, Suzuki, Rikio et al. · 2015 · Clinical Cancer Research
60. Molecular Pathways: Coexpression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy
    Christopher J. Nirschl, Charles G. Drake · 2013 · Clinical Cancer Research
61. Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
    Emma M. Kerr, Edoardo Gaude, Frances K. Turrell, Christian Frezza, Carla P. Martins · 2016 · Nature
62. T cell–induced CSF1 promotes melanoma resistance to PD1 blockade
    Neubert, Natalie J., Schmittnaegel, Martina, Bordry, Natacha, Nassiri, Sina, Wald, Noémie, Martignier, Christophe, Tillé, Laure, Homicsko, Krisztian, Damsky, William, Maby-El Hajjami, Hélène et al. · 2018 · Science Translational Medicine
63. HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
    Jason M. Miska, Catalina Lee-Chang, Aida Rashidi, Megan E. Muroski, Alan Lee Chang, Aurora Lopez‐Rosas, Peng Zhang, Wojciech K. Panek, Álex Cordero, Yu Han et al. · 2019 · Cell Reports
64. Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment
    Caglar Cekic, Yuan‐Ji Day, Duygu Sağ, Joel M Linden · 2014 · Cancer Research
65. Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System
    Hideki Okazawa, Sei‐ichiro Motegi, Naoko Ohyama, Hiroshi Ohnishi, Takeshi Tomizawa, Yoriaki Kaneko, Per‐Arne Oldenborg, Osamu Ishikawa, Takashi Matozaki · 2005 · The Journal of Immunology
66. Methods for defining distinct bioenergetic profiles in platelets, lymphocytes, monocytes, and neutrophils, and the oxidative burst from human blood
    Balu K. Chacko, Philip Adam Kramer, Saranya Ravi, Michelle Smith Johnson, Robert W. Hardy, Scott W. Ballinger, Victor M. Darley-Usmar · 2013 · Laboratory Investigation
67. Mitochondrial Priming by CD28
    Ramon I. Klein Geltink, David O’Sullivan, Mauro Corrado, Anna Bremser, Michael D. Buck, Joerg Martin Buescher, Elke Firat, Xuekai Zhu, Gabriele Niedermann, George Caputa et al. · 2017 · Cell
68. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47−mediated ‘don’t-eat-me’ signal
    Mingen Liu, Roddy S. O’Connor, Sophie Trefely, Kathleen L. Graham, Nathaniel W. Snyder, Gregory Lawrence Beatty · 2019 · Nature Immunology
69. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation
    Laurel A. Monticelli, Michael D. Buck, Anne-Laure Flamar, Steven A. Saenz, Elia D. Tait Wojno, Naomi A. Yudanin, Lisa C. Osborne, Matthew R. Hepworth, Sara V. Tran, Hans-Reimer Rodewald et al. · 2016 · Nature Immunology
70. Oncogenic PIK3CA mutations reprogram glutamine metabolism in colorectal cancer
    Hao, Yujun, Samuels, Yardena, Li, Qingling, Krokowski, Dawid, Guan, Bo-Jhih, Wang, Chao, Jin, Zhicheng, Dong, Bohan, Cao, Bo, Feng, Xiujing et al. · 2016 · Nature Communications
71. ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors
    Ursula Schenk, Michela Frascoli, Michele Proietti, Robert Geffers, Elisabetta Traggiai, Jan Buer, Camillo Ricordi, Astrid Maria Westendorf, Fabio Grassi · 2011 · Science Signaling
72. Hypoxia downregulates the expression of activating receptors involved in NK ‐cell‐mediated target cell killing without affecting ADCC
    Mirna Balsamo, Claudia Manzini, Gabriella Pietra, Federica Raggi, Fabiola Blengio, Maria Cristina Mingari, Luigi Varesio, Lorenzo Moretta, Maria Carla Bosco, Massimo Vitale · 2013 · European Journal of Immunology
73. Redox regulation in metabolic programming and inflammation
    Helen R. Griffiths, Dan Gao, Chathyan Pararasa · 2017 · Redox Biology
74. Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes
    Anja Hasenberg, Mike Hasenberg, Linda Männ, Franziska Neumann, Lars Borkenstein, Manuel Stecher, Andreas Kraus, Daniel Robert Engel, Anika Grüneboom, Pegah Seddigh et al. · 2015 · Nature Methods
75. Cancer vaccines
    Lisa Helene Butterfield · 2015 · BMJ
76. Tissue-resident memory T cells at the center of immunity to solid tumors
    Derk Amsen, Klaas P. J. M. van Gisbergen, Pleun Hombrink, René A. W. van Lier · 2018 · Nature Immunology
77. A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
    Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prébet, Aude Charbonnier, Anne Etienne, Pascale André, François Romagné, Don Benson et al. · 2012 · Blood
78. Clinical Experiences With Anti-CD137 and Anti-PD1 Therapeutic Antibodies
    Paolo A. Ascierto, Ester Simeone, Mario Sznol, Yang‐Xin Fu, Ignacio Melero · 2010 · Seminars in Oncology
79. Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier
    Vacanti, Nathaniel M., Divakaruni, Ajit S., Green, Courtney R., Parker, Seth J., Henry, Robert R., Ciaraldi, Theodore P., Murphy, Anne N., Metallo, Christian M. · 2014 · Molecular Cell
80. Impaired Cholesterol Efflux in Senescent Macrophages Promotes Age-Related Macular Degeneration
    Sene, Abdoulaye, Khan, Aslam A., Cox, Douglas, Nakamura, Rei E.I., Santeford, Andrea, Kim, Bryan M., Sidhu, Rohini, Onken, Michael D., Harbour, J. William, Hagbi-Levi, Shira et al. · 2013 · Cell Metabolism
81. Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy
    Nicole Glodde, Tobias Bald, Debby Konijnenberg, Kyohei Nakamura, Jake S. O’Donnell, Sabrina Szczepanski, Maria Brandes, Sarah Eickhoff, Indrajit Das, Naveen Shridhar et al. · 2017 · Immunity
82. 6-Phosphofructo-2-kinase (pfkfb3) Gene Promoter Contains Hypoxia-inducible Factor-1 Binding Sites Necessary for Transactivation in Response to Hypoxia
    Mercè Obach, Àurea Navarro‐Sabaté, Jaime Caro, Xianguo Kong, Joan Duran, Marta Gómez, Jose Carlos Perales, Francesc Ventura, José Luís Rosa, Ramón Bartrons · 2004 · Journal of Biological Chemistry
83. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
    Shahneen Kaur Sandhu, Kyri P. Papadopoulos, Peter C.C. Fong, Amita Patnaik, Christina Messiou, David Olmos, George Wang, Brenda J. Tromp, Thomas A. Puchalski, Frances R. Balkwill et al. · 2013 · Cancer Chemotherapy and Pharmacology
84. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation
    L. Vogt, N. Schmitz, Michael Odo Kurrer, M. Bauer, H. I. Hinton, Silvia Behnke, Dominique Gatto, Peter Sebbel, Roger R. Beerli, Ivo Sonderegger et al. · 2006 · Journal of Clinical Investigation
85. Metabolic maintenance of cell asymmetry following division in activated T lymphocytes
    Katherine Verbist, Cliff S. Guy, Sandra Milasta, Swantje Liedmann, Marcin M. Kamiński, Ruoning Wang, Douglas R. Green · 2016 · Nature
86. Epithelial–Mesenchymal Transition (EMT) Induced by TNF-α Requires AKT/GSK-3β-Mediated Stabilization of Snail in Colorectal Cancer
    Hao Wang, Hongsheng Wang, Bin-Hua Zhou, Cui-Lin Li, Fan Zhang, Xianfeng Wang, Ge Zhang, Xianzhang Bu, Shaohui Cai, Jun Du · 2013 · PLoS ONE
87. NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
    Paolo Carrega, Fabrizio Loiacono, Emma Di Carlo, Angelo Scaramuccia, Marco Mora, Romana Conte, Roberto Benelli, Grazia Maria Spaggiari, Claudia Cantoni, Stefania Campana et al. · 2015 · Nature Communications
88. mTORC 1 and mTORC 2 as regulators of cell metabolism in immunity
    Monika Linke, Stephanie Deborah Fritsch, Nyamdelger Sukhbaatar, Markus Hengstschläger, Thomas Weichhart · 2017 · FEBS Letters
89. Transfection of chimeric anti‐CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells
    Jiang, Hua, Zhang, Wenhao, Shang, Peipei, Zhang, Hui, Fu, Weijun, Ye, Fei, Zeng, Tianmei, Huang, Hejing, Zhang, Xueguang, Sun, Wanping et al. · 2014 · Molecular Oncology
90. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors
    Weiss, Jonathan M., Davies, Luke C., Karwan, Megan, Ileva, Lilia, Ozaki, Michelle K., Cheng, Robert Y.S., Ridnour, Lisa A., Annunziata, Christina M., Wink, David A., McVicar, Daniel W. · 2018 · Journal of Clinical Investigation
91. Retargeting of natural killer–cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction
    Christoph Uherek, Torsten Tonn, Barbara Uherek, Sven Becker, Barbara S. Schnierle, Hans-Georg Klingemann, Winfried S. Wels · 2002 · Blood
92. Tie2-Expressing Monocytes and Tumor Angiogenesis: Regulation by Hypoxia and Angiopoietin-2
    Claire E. Lewis, Michele De Palma, Luigi Naldini · 2007 · Cancer Research
93. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.
    Q Shi, James L. Abbruzzese, Suyun Huang, I. J. Fidler, Qian Xiong, Ke Xie · 1999 · PubMed
94. Cancer Cells Become Susceptible to Natural Killer Cell Killing after Exposure to Histone Deacetylase Inhibitors Due to Glycogen Synthase Kinase-3–Dependent Expression of MHC Class I–Related Chain A and B
    Søren Skov, Marianne Terndrup Pedersen, Lars Ole Andresen, Per thor Straten, Anders Woetmann, Niels Ødum · 2005 · Cancer Research
95. Distinct Metabolic Requirements of Exhausted and Functional Virus-Specific CD8 T Cells in the Same Host
    Anna Schurich, Laura J. Pallett, Danyal Jajbhay, Jessica E. Wijngaarden, Itziar Otano, Upkar S. Gill, Navjyot K. Hansi, Patrick T.F. Kennedy, Eleni Nastouli, Richard J.C. Gilson et al. · 2016 · Cell Reports
96. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells
    M. Angela, Yusuke Endo, Hikari K. Asou, Takeshi Yamamoto, Damon John Tumes, Hirotake Tokuyama, Koutaro Yokote, Toshinori Nakayama · 2016 · Nature Communications
97. Host tissue determinants of tumour immunity
    Hélène Salmon, Romain Remark, Sacha Gnjatic, Miriam Mérad · 2019 · Nature reviews. Cancer
98. Complement Regulates Nutrient Influx and Metabolic Reprogramming during Th1 Cell Responses
    Martin V. Kolev, Sarah Dimeloe, Gaëlle Le Friec, Alexander Andreas Navarini, Giuseppina Arbore, Giovanni A. M. Povoleri, Marco Fischer, Réka Belle, Jordan Loeliger, Leyla Develioglu et al. · 2015 · Immunity
99. 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
    Todd Bartkowiak, Michael A. Curran · 2015 · Frontiers in Oncology
100. Blocking Hypoxia-Induced Autophagy in Tumors Restores Cytotoxic T-Cell Activity and Promotes Regression
     Noman, Muhammad Zaeem, Janji, Bassam, Kaminska, Bozena, Van Moer, Kris, Pierson, Sandrine, Przanowski, Piotr, Buart, Stéphanie, Berchem, Guy, Romero, Pedro, Mami-Chouaib, Fathia et al. · 2011 · Cancer Research
101. The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity
     Damya Laoui, Jiri Keirsse, Yannick Morias, Eva van Overmeire, X. Geeraerts, Y. Elkrim, M. Kiss, Evangelia Bolli, Qods Lahmar, D. Sichien et al. · 2016 · Nature Communications
102. Neutrophils recruit regulatory T‐cells into tumors via secretion of CCL17—A new mechanism of impaired antitumor immunity
     Inbal Mishalian, Rachel Bayuh, Evgeniy B. Eruslanov, Janna Michaeli, Liran Levy, Lida Zolotarov, Sunil Kumar Singhal, Steven Μ. Albelda, Zvi Granot, Zvi G. Fridlender · 2014 · International Journal of Cancer
103. Obesity Drives Th17 Cell Differentiation by Inducing the Lipid Metabolic Kinase, ACC1
     Yusuke Endo, Hikari K. Asou, Nao Matsugae, Kiyoshi Hirahara, Kenta Shinoda, Damon John Tumes, Hirotake Tokuyama, Koutaro Yokote, Toshinori Nakayama · 2015 · Cell Reports
104. Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth
     W. Hansen, Marina Hutzler, Simone Abel, C. Alter, C. Stockmann, S. Kliche, J. Albert, T. Sparwasser, S. Sakaguchi, A. Westendorf et al. · 2012 · Journal of Experimental Medicine
105. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210
     Haopeng Wang, Henrik Flach, Michio Onizawa, Lai Wei, Michael T. McManus, Arthur Weiss · 2014 · Nature Immunology
106. IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function
     Magali Noval Rivas, Oliver T. Burton, Hans C. Oettgen, Talal A. Chatila · 2016 · Journal of Allergy and Clinical Immunology
107. Inducers of immunogenic cancer cell death
     Aleksandra M. Dudek, Abhishek Dinkarnath Garg, Dmitri V. Krysko, Dirk De Ruysscher, Patrizia Agostinis · 2013 · Cytokine & Growth Factor Reviews
108. DAP12-Based Activating Chimeric Antigen Receptor for NK Cell Tumor Immunotherapy
     Katrin Töpfer, Marc Cartellieri, Susanne Michen, Ralf Wiedemuth, Nadja Müller, Dirk Lindemann, Michael Philipp Bachmann, Monika Füssel, Gabriele Schackert, Achim Temme · 2015 · The Journal of Immunology
109. The A3 Adenosine Receptor: History and Perspectives
     Pier Andrea Borea, Katia Varani, Fabrizio Vincenzi, Pier Giovanni Baraldi, Mojgan Aghazadeh Tabrizi, Stefania Merighi, Stefania Gessi · 2014 · Pharmacological Reviews
110. Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control
     Michelle Li Wen Hong, Anne‐Laure Puaux, Caleb Weihao Huang, Laure Loumagne, Charlene Tow, Charles Reay Mackay, Masashi Kato, Armelle Prévost‐Blondel, Marie‐Françoise Avril, Alessandra Nardin et al. · 2011 · Cancer Research
111. The Multifaceted Role of Perivascular Macrophages in Tumors
     Claire E. Lewis, Allison S. Harney, Jeffrey W. Pollard · 2016 · Cancer Cell
112. Tumor-Derived G-CSF Facilitates Neoplastic Growth through a Granulocytic Myeloid-Derived Suppressor Cell-Dependent Mechanism
     Jeremy D. Waight, Qiang Hu, Austin Miller, Song Liu, Scott I. Abrams · 2011 · PLoS ONE
113. HLA-G Proteins in Cancer: Do They Provide Tumor Cells with an Escape Mechanism?
     Nathalie Rouas‐Freiss, Philippe Moreau, Soldano Ferrone, Edgardo Delfino Carosella · 2005 · Cancer Research
114. Cell-Intrinsic Glycogen Metabolism Supports Early Glycolytic Reprogramming Required for Dendritic Cell Immune Responses
     Phyu M. Thwe, Leonard R. Pelgrom, Rachel S. Cooper, Saritha Beauchamp, Julie A. Reisz, Angelo D’Alessandro, Bart Everts, Eyal Amiel · 2017 · Cell Metabolism
115. A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma
     Don M. Benson, Craig C. Hofmeister, Swaminathan Padmanabhan, Attaya Suvannasankha, Sundar Jagannath, Rafat Abonour, Courtney E. Bakan, Pascale André, Yvonne Adeduni Efebera, Jérôme Tiollier et al. · 2012 · Blood
116. Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor
     Deepak Mittal, Arabella Young, Kimberley A. Stannard, Michelle C.R. Yong, Michele W.L. Teng, Bertrand Allard, John Stagg, Mark John Smyth · 2014 · Cancer Research
117. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of β ₂ integrin gene expression
     Kong, Tianqing, Eltzschig, Holger K., Karhausen, Jorn, Colgan, Sean P., Shelley, C. Simon · 2004 · Proceedings of the National Academy of Sciences
118. Advantages and applications of CAR-expressing natural killer cells
     Wolfgang Glienke, Ruth Esser, Christoph Priesner, Julia D. Suerth, Axel Schambach, Winfried S. Wels, Manuel Grez, Stephan Kloeß, Lubomir Arseniev, Ulrike Koehl · 2015 · Frontiers in Pharmacology
119. Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
     David C. Clever, Rahul Roychoudhuri, Michael G. Constantinides, Michael H. Askenase, Madhusudhanan Sukumar, Christopher Austin Klebanoff, Robert L Eil, Heather D. Hickman, Zhiya Yu, Jenny H. Pan et al. · 2016 · Cell
120. Tumor stroma: a complexity dictated by the hypoxic tumor microenvironment
     Andrea Casazza, Giusy Di Conza, Mathias Wenes, Veronica Finisguerra, Sofie Deschoemaeker, Massimiliano Mazzone · 2013 · Oncogene
121. Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
     Le, Dung T., Jaffee, Elizabeth M. · 2012 · Cancer Research
122. MYC and tumor metabolism: chicken and egg
     Dejure, Francesca R, Eilers, Martin · 2017 · The EMBO Journal
123. Modulation of amplitude and direction ofin vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens
     Jong J. Kim, Neil N. Trivedi, Liesl K. Nottingham, Lake Daniel Morrison, Anthony Tsai, Yin Hu, Sundarasamy Mahalingam, Kesen Dang, Lois Ahn, Nicole K. Doyle et al. · 1998 · European Journal of Immunology
124. Dendritic Cell Vaccination in Combination with Anti-CD25 Monoclonal Antibody Treatment: A Phase I/II Study in Metastatic Melanoma Patients
     Joannes F.M. Jacobs, Cornelis J.A. Punt, Willem Joost Lesterhuis, Roger P.M. Sutmuller, Heather Brouwer, Nicole M. Scharenborg, Ina S. Klasen, Luuk B. Hilbrands, Carl Gustav Figdor, I. Jolanda M. de Vries et al. · 2010 · Clinical Cancer Research
125. Immature Low-Density Neutrophils Exhibit Metabolic Flexibility that Facilitates Breast Cancer Liver Metastasis
     Brian E. Hsu, Sébastien Tabariès, Radia Marie Johnson, Sylvia Andrzejewski, Julien Senécal, Camille Lehuédé, Matthew G. Annis, Eric H. Ma, Sandra Völs, LeeAnn Ramsay et al. · 2019 · Cell Reports
126. Neutrophil extracellular traps in cancer progression
     Jonathan Cools‐Lartigue, Jonathan David Spicer, Sara Najmeh, Lorenzo Edwin Ferri · 2014 · Cellular and Molecular Life Sciences
127. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1α under hypoxic conditions in trophoblast-derived cells
     Hayashi, Masami, Sakata, Masahiro, Takeda, Takashi, Yamamoto, Toshiya, Okamoto, Yoko, Sawada, Kenjiro, Kimura, Akiko, Minekawa, Ryoko, Tahara, Masahiro, Tasaka, Keiichi et al. · 2004 · Journal of Endocrinology
128. Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
     Madeleine A. Duvic, Lauren C. Pinter‐Brown, Francine M. Foss, Lubomir Sokol, Jeffrey L. Jorgensen, Pramoda Challagundla, Karen M. Dwyer, Xiaoping Zhang, Michael R. Kurman, Rocco Ballerini et al. · 2015 · Blood
129. Human NK cell lytic granules and regulation of their exocytosis
     Konrad Krzewski, John E. Coligan · 2012 · Frontiers in Immunology
130. Oxidized LDL Induces Alternative Macrophage Phenotype through Activation of CD36 and PAFR
     Francisco J. O. Rios, Marianna M. Koga, Mateus Fila Pecenin, Matheus Ferracini, Magnus Gidlund, Sônia Jancar · 2013 · Mediators of Inflammation
131. Asymmetric inheritance of mTORC1 kinase activity during division dictates CD8+ T cell differentiation
     Kristen N. Pollizzi, Im‐Hong Sun, Chirag H. Patel, Ying-Chun Lo, Min Hee Oh, Adam Tully Waickman, Ada J Tam, Richard L. Blosser, Jiayu Wen, Greg M. Delgoffe et al. · 2016 · Nature Immunology
132. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
     Haiping Wang, Fabien Franco, Ping‐Chih Ho · 2017 · Trends in cancer
133. Podoplanin-Expressing Macrophages Promote Lymphangiogenesis and Lymphoinvasion in Breast Cancer
     Paweł Bieniasz-Krzywiec, Rosa Martín‐Pérez, Manuel Ehling, Melissa García‐Caballero, Sotiria Pinioti, Samantha Pretto, Roel Kroes, Chiara Aldeni, Mario Di Matteo, Hans Prenen et al. · 2019 · Cell Metabolism
134. Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
     Erin A. Marshall, Kevin W. Ng, Sonia H.Y. Kung, Emma M. Conway, Victor D. Martínez, Elizabeth C. Halvorsen, David A. Rowbotham, Emily A. Vucic, Adam W. Plumb, Daiana D. Becker‐Santos et al. · 2016 · Molecular Cancer
135. Anticancer Cytokines: Biology and Clinical Effects of Interferon-α2, Interleukin (IL)-2, IL-15, IL-21, and IL-12
     Theofanis Floros, Ahmad A. Tarhini · 2015 · Seminars in Oncology
136. TNF-α is critical for antitumor but not antiviral T cell immunity in mice
     Thomas Calzascia, Marc Pellegrini, Håkan Hall, Laurent Sabbagh, Nobuyuki Ono, Alisha R. Elford, Tak W. Mak, Pamela S. Ohashi · 2007 · Journal of Clinical Investigation
137. Tisagenlecleucel — the first approved CAR-T-cell therapy: implications for payers and policy makers
     Prasad, Vinay · 2018 · Nature Reviews Clinical Oncology
138. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome.
     Agnès Bellocq, Martine Antoine, Antoine Flahault, C Philippe, Bruno Crestani, Jean‐François Bernaudin, Charles M. Mayaud, Bernard J. Milleron, Laurent Baud, Jacques L. Cadranel · 1998 · PubMed Central
139. Triggering of Natural Killer Cells by the Costimulatory Molecule CD80 (B7-1)
     Benedict J. Chambers, Margarita Salcedo, Hans‐Gustaf Ljunggren · 1996 · Immunity
140. Neutrophil infiltration into human gliomas
     Gianluca Fossati, Giovanni Ricevuti, Steven W. Edwards, Carol A Walker, Alison Dalton, Marco Rossi · 1999 · Acta Neuropathologica
141. Glycolytic metabolism is essential for CCR7 oligomerization and dendritic cell migration
     Hannah Guak, Sara Al Habyan, Eric H. Ma, Haya Aldossary, Maia Al‐Masri, So-Yoon Won, Thomas Ying, Elizabeth D. Fixman, Russell G. Jones, Luke Martin McCaffrey et al. · 2018 · Nature Communications
142. Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition
     Liu, Xia, Mo, Wei, Ye, Jian, Li, Lingyun, Zhang, Yanping, Hsueh, Eddy C., Hoft, Daniel F., Peng, Guangyong · 2018 · Nature Communications
143. Unique pattern of neutrophil migration and function during tumor progression
     Sima Patel, Shuyu Fu, Jérôme Mastio, George A. Dominguez, Abhilasha Purohit, Andrew V. Kossenkov, Cindy Lin, Kevin M. Alicea-Torres, Mohit Sehgal, Yulia Nefedova et al. · 2018 · Nature Immunology
144. IL-12 initiates tumor rejection via lymphoid tissue–inducer cells bearing the natural cytotoxicity receptor NKp46
     Maya Eisenring, Johannes vom Berg, Glen Kristiansen, Elisabeth Saller, Burkhard Becher · 2010 · Nature Immunology
145. Angiopoietin 2 Stimulates TIE2-Expressing Monocytes To Suppress T Cell Activation and To Promote Regulatory T Cell Expansion
     Coffelt, Seth B, Chen, Yung-Yi, Muthana, Munitta, Welford, Abigail F, Tal, Andrea O, Scholz, Alexander, Plate, Karl H, Reiss, Yvonne, Murdoch, Craig, De Palma, Michele et al. · 2011 · The Journal of Immunology
146. Adaptive landscapes and emergent phenotypes: why do cancers have high glycolysis?
     Robert J. Gillies, Robert A. Gatenby · 2007 · Journal of Bioenergetics and Biomembranes
147. Carlumab, an anti-C-C chemokine ligand 2 monoclonal antibody, in combination with four chemotherapy regimens for the treatment of patients with solid tumors: an open-label, multicenter phase 1b study
     Irene Braña, Antonio Calles, Patricia Mucci LoRusso, Lorrin Yee, Thomas A. Puchalski, Shobha Seetharam, Bob Zhong, Carla J. de Boer, Josep M. Tabernero, Emiliano Calvo · 2014 · Targeted Oncology
148. The paradox of Th17 cell functions in tumor immunity
     Zahra Asadzadeh, Hamed Mohammadi, Elham Safarzadeh, Maryam Hemmatzadeh, Ahmad Mahdian-shakib, Farhad Jadidi‐Niaragh, Gholamreza Azizi, Behzad Baradaran · 2017 · Cellular Immunology
149. Hypoxia Induced Impairment of NK Cell Cytotoxicity against Multiple Myeloma Can Be Overcome by IL-2 Activation of the NK Cells
     Subhashis Sarkar, Wilfred T.V. Germeraad, Kasper M. A. Rouschop, Elisabeth M. P. Steeghs, Michel van Gelder, Gerard M.J. Bos, Lotte Wieten · 2013 · PLoS ONE
150. Perforin: an important player in immune response
     Iwona Osińska, Katarzyna Popko, Urszula Anna Demkow · 2014 · Central European Journal of Immunology
151. Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells
     Tina Müller, Christoph Uherek, Guitta Maki, Kai Uwe Chow, Annemarie Schimpf, Hans-Georg Klingemann, Torsten Tonn, Winfried S. Wels · 2007 · Cancer Immunology Immunotherapy
152. Metabolic Control of Dendritic Cell Functions: Digesting Information
     Stefanie K. Wculek, Sofía C. Khouili, Elena Priego, Ignacio Heras‐Murillo, David Sancho · 2019 · Frontiers in Immunology
153. A Metabolic Shift toward Pentose Phosphate Pathway Is Necessary for Amyloid Fibril- and Phorbol 12-Myristate 13-Acetate-induced Neutrophil Extracellular Trap (NET) Formation
     Estefania P. Azevedo, Natalia Cadaxo Rochael, Anderson B. Guimarães-Costa, Thiago S. DeSouza-Vieira, Juliana Ganilho, Elvira M. Saraiva, Fernando Lucas Palhano, Débora Foguel · 2015 · Journal of Biological Chemistry
154. Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
     Austin R. Pantel, Angela Teixeira, Elias K. Haddad, Elizabeth G. Wood, Ralph M. Steinman, Maria Paula Longhi · 2014 · PLoS Biology
155. On immunosurveillance in human cancer.
     L Thomas · 1983 · PubMed
156. Tumour necrosis factor and cancer
     J.P. Waters, Jordan S. Pober, John R. Bradley · 2013 · The Journal of Pathology
157. The Intratumoral Balance between Metabolic and Immunologic Gene Expression Is Associated with Anti–PD-1 Response in Patients with Renal Cell Carcinoma
     Maria Libera Ascierto, Tracee L. McMiller, Alan E. Berger, Ludmila Danilova, Robert A. Anders, George Jabboure Netto, Haiying Xu, Theresa S. Pritchard, Jinshui Fan, Chris Cheadle et al. · 2016 · Cancer Immunology Research
158. Regulator of Fatty Acid Metabolism, Acetyl Coenzyme A Carboxylase 1, Controls T Cell Immunity
     JangEun Lee, Matthew C. Walsh, Kyle L. Hoehn, David Ernest James, E. John Wherry, Yongwon Choi · 2014 · The Journal of Immunology
159. A Pck1-directed glycogen metabolic program regulates formation and maintenance of memory CD8+ T cells
     Ruihua Ma, Tiantian Ji, Yi Zhang, Wenqian Dong, Xinfeng Chen, Pingwei Xu, Degao Chen, Xiaoyu Liang, Xiaonan Yin, Yuying Liu et al. · 2017 · Nature Cell Biology
160. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity
     Jee H. Lee, Chris Elly, Yoon Park, Yun‐Cai Liu · 2015 · Immunity
161. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease
     Kamran Ghoreschi, Arian D. J. Laurence, Xiang‐Ping Yang, Kiyoshi Hirahara, John J. O’Shea · 2011 · Trends in Immunology
162. Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors
     Olga Sedlakova · 2014 · Frontiers in Physiology
163. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer.
     G. Perrone, P. Ruffini, V. Catalano, C. Spino, D. Santini, P. Muretto, Chiara Spoto, C. Zingaretti, V. Sisti, P. Alessandroni et al. · 2008 · European Journal of Cancer
164. Vascular Endothelial Growth Factor Receptor 2 Mediates Macrophage Infiltration into Orthotopic Pancreatic Tumors in Mice
     Sean Patrick Dineen, Kristi D. Lynn, Shane E. Holloway, Andrew F. Miller, James Patrick Sullivan, David S. Shames, Adam W. Beck, Carlton C. Barnett, Jason B. Fleming, Rolf A. Brekken · 2008 · Cancer Research
165. IL-4-producing ILC2s are required for the differentiation of TH2 cells following Heligmosomoides polygyrus infection
     Victoria S. Pelly, Yashaswini Kannan, Stephanie M. Coomes, Lewis J. Entwistle, Dominik Rückerl, Benedict P. Seddon, Andrew S. MacDonald, A. McKenzie, Mark S. Wilson · 2016 · Mucosal Immunology
166. STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils
     Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J. et al. · 2006 · Blood
167. IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancer
     Rita Rotondo, Gaia Barisione, Luca Mastracci, Francesco Grossi, Anna Maria Orengo, Roberta Costa, Mauro Truini, Marina Fabbi, Silvano Ferrini, Ottavia Barbieri · 2009 · International Journal of Cancer
168. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
     Omkar Uday Kawalekar, Roddy S. O’ Connor, Joseph A. Fraietta, Lili Guo, Shannon E. McGettigan, Avery D. Posey, Prachi R. Patel, Sònia Guedan, John Scholler, Brian Keith et al. · 2016 · Immunity
169. Regulation of T cells by mTOR: the known knowns and the known unknowns
     Kristen N. Pollizzi, Jonathan D. Powell · 2014 · Trends in Immunology
170. IFN-γ-Dependent Inhibition of Tumor Angiogenesis by Tumor-Infiltrating CD4+ T Cells Requires Tumor Responsiveness to IFN-γ
     Gregory Lawrence Beatty, Yvonne Y.W. Paterson · 2001 · The Journal of Immunology
171. Tumor Promotion by Intratumoral Plasmacytoid Dendritic Cells Is Reversed by TLR7 Ligand Treatment
     Isabelle Le Mercier, Dominique Poujol, Amélien Sanlaville, Vanja Sisirak, Michael Gobert, Isabelle Durand, Bertrand Dubois, Isabelle Treilleux, Jacqueline Marvel, Jaromir Vlach et al. · 2013 · Cancer Research
172. Hypoxia-Driven Immunosuppressive Metabolites in the Tumor Microenvironment: New Approaches for Combinational Immunotherapy
     Yiliang Li, Sapna Pradyuman Patel, Jason Roszik, Yong Wen Qin · 2018 · Frontiers in Immunology
173. Prognostic Value of Intratumoral Neutrophils in Advanced Gastric Carcinoma in a High-Risk Area in Northern Italy
     Rosario Alberto Caruso, Rino Bellocco, Marcello Pagano, Giovanni Bertoli, Luciana Concetta Rigoli, C Inferrera · 2002 · Modern Pathology
174. CD47 in the Tumor Microenvironment Limits Cooperation between Antitumor T-cell Immunity and Radiotherapy
     David R. Soto‐Pantoja, Masaki Terabe, Arunima Ghosh, Lisa A. Ridnour, William DeGraff, David A. Wink, Jay A. Berzofsky, David D. Roberts · 2014 · Cancer Research
175. Survival, Persistence, and Progressive Differentiation of Adoptively Transferred Tumor-Reactive T Cells Associated with Tumor Regression
     Jianping Huang, Hung T. Khong, Mark E. Dudley, Mona El‐Gamil, Yong F. Li, Steven A. Rosenberg, Paul F. Robbins · 2005 · Journal of Immunotherapy
176. Hypoxia causes an increase in phagocytosis by macrophages in a HIF-1α-dependent manner
     Rahul Anand, Steven C. Gribar, Jun Li, Jeff W. Kohler, Maria F. Branca, Theresa D. Dubowski, Chhinder P. Sodhi, David Joel Hackam · 2007 · Journal of Leukocyte Biology
177. Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice
     Walmsley, Sarah R., Chilvers, Edwin R., Thompson, Alfred A., Vaughan, Kathryn, Marriott, Helen M., Parker, Lisa C., Shaw, Gary, Parmar, Selina, Schneider, Martin, Sabroe, Ian et al. · 2011 · Journal of Clinical Investigation
178. Mitochondria-Endoplasmic Reticulum Contact Sites Function as Immunometabolic Hubs that Orchestrate the Rapid Recall Response of Memory CD8+ T Cells
     Glenn R. Bantug, Marco Fischer, Jasmin Grählert, Maria Luisa Balmer, Gunhild Unterstab, Leyla Develioglu, Rebekah Steiner, Lianjun Zhang, Ana S.H. Costa, Patrick M. Gubser et al. · 2018 · Immunity
179. Dendritic Cell Reprogramming by Endogenously Produced Lactic Acid
     Aikaterini Nasi, Tünde Fekete, Akilan Krishnamurthy, Stuart G. Snowden, Éva Rajnavölgyi, Anca I. Catrina, Craig E. Wheelock, Nancy Vivar, Bence Réthi · 2013 · The Journal of Immunology
180. Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity
     Chong T. Luo, Will Liao, Saïda Dadi, Ahmed Toure, Ming O. Li · 2016 · Nature
181. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells
     Lingwei Wang, Sten Eirik W. Jacobsen, Anders A Bengtsson, David Erlinge · 2004 · BMC Immunology
182. NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin
     Ruth Esser, Tina Müller, Dörthe Stefes, Stephan Kloeß, Diana Seidel, Stephen D. Gillies, Christel Aperlo, James S. Huston, Christoph Uherek, Kurt Schönfeld et al. · 2011 · Journal of Cellular and Molecular Medicine
183. The Warburg effect in 2012
     Jean‐Pierre Bayley, Peter Devilee · 2011 · Current Opinion in Oncology
184. Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor
     Christiane Sahm, Kurt Schönfeld, Winfried S. Wels · 2012 · Cancer Immunology Immunotherapy
185. Is CD47 an innate immune checkpoint for tumor evasion?
     Xiaojuan Liu, Hyunwoo Kwon, Zihai Li, Yang‐Xin Fu · 2017 · Journal of Hematology & Oncology
186. Dendritic Cell Metabolism and Function in Tumors
     Paolo Giovanelli, Tito Alejandro Sandoval, Juan R. Cubillos‐Ruiz · 2019 · Trends in Immunology
187. The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
     Asís Palazón, Iván Martínez‐Forero, Álvaro Teijeira, Aizea Morales‐Kastresana, Carlos Alfaro, Miguel F. Sanmamed, José Luis Perez‐Gracia, Iván Peñuelas, Sandra Hervás‐Stubbs, Ana Rouzaut et al. · 2012 · Cancer Discovery
188. The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis
     Noman, Muhammad Zaeem, Buart, Stéphanie, Van Pelt, Jos, Richon, Catherine, Hasmim, Meriem, Leleu, Nathalie, Suchorska, Wictoria Maria, Jalil, Abdelali, Lecluse, Yann, El Hage, Faten et al. · 2009 · The Journal of Immunology
189. Acidic Extracellular pH Induces Matrix Metalloproteinase-9 Expression in Mouse Metastatic Melanoma Cells through the Phospholipase D-Mitogen-activated Protein Kinase Signaling
     Yukio Kato, Charles A. Lambert, Alain Colige, Pierre Mineur, Agnès Noël, Françis Frankenne, Jean‐Michel Foidart, Masaya Baba, Ryu‐Ichiro Hata, Kaoru Miyazaki et al. · 2005 · Journal of Biological Chemistry
190. High Sensitivity of CD4+CD25+ Regulatory T Cells to Extracellular Metabolites Nicotinamide Adenine Dinucleotide and ATP: A Role for P2X7 Receptors
     Fred Aswad, Hiroki Kawamura, Gunther Dennert · 2005 · The Journal of Immunology
191. Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis
     Guo-Xiang Ruan, Andrius Kazlauskas · 2013 · Journal of Biological Chemistry
192. Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways
     Kai Li, Shuai Qu, Xi Chen, Qiong Wu, Ming Shi · 2017 · International Journal of Molecular Sciences
193. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism
     Jialin Li, Bo Diao, Sheng Jie Guo, Xiaoyong Huang, Chengying Yang, Zeqing Feng, Weiming Yan, Qin Ning, Lixin Zheng, Yongwen Chen et al. · 2017 · Nature Communications
194. Glucose represses dendritic cell-induced T cell responses
     Simon J. Lawless, Nidhi Kedia-Mehta, Jessica F. Walls, Ryan McGarrigle, Orla Convery, Linda V. Sinclair, Marı́a N. Navarro, James T. Murray, David K. Finlay · 2017 · Nature Communications
195. A Phase I Trial of the Anti-KIR Antibody IPH2101 and Lenalidomide in Patients with Relapsed/Refractory Multiple Myeloma
     Don M. Benson, Adam D. Cohen, Sundar Jagannath, Nikhil C. Munshi, Gary Spitzer, Craig C. Hofmeister, Yvonne Adeduni Efebera, Pascale André, Robert Albert Zerbib, Michael A. Caligiuri · 2015 · Clinical Cancer Research
196. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma
     Si‐Rui Ma, Wei‐Wei Deng, Jianfeng Liu, Liang Mao, Guang‐Tao Yu, Lin‐Lin Bu, Ashok B. Kulkarni, Wen‐Feng Zhang, Zhi‐Jun Sun · 2017 · Molecular Cancer
197. Inhibition of IL-10 expression by IFN-gamma up-regulates transcription of TNF-alpha in human monocytes.
     R. P. Donnelly, S. Freeman, Mark P. Hayes · 1995 · Journal of Immunology
198. Tumor-infiltrating neutrophils in pancreatic neoplasia
     Michelle Dian Reid, Olca Baştürk, Duangpen Thirabanjasak, Ralph H. Hruban, David S. Klimstra, Pelin Bağcı, Deniz Altinel, Volkan N. Adsay · 2011 · Modern Pathology
199. Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells
     Adam Blaisdell, Amandine Créquer-Grandhomme, Devin Columbus, Takiko Daikoku, Khush Mittal, Sudhansu K. Dey, Adrian Erlebacher · 2015 · Cancer Cell
200. Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma
     Jumei Shi, Guido J. K. Tricot, Tarun K. Garg, Priyangi A. Malaviarachchi, Susann M. Szmania, Rachel E. Kellum, Brian Storrie, Arend Mulder, John D. Shaughnessy, Bart Barlogie et al. · 2007 · Blood